Related Experiment Video
Updated: Aug 28, 2025
09:03
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
4.9K
Post COVID and Apheresis - Where are we Standing?
Charlotte Steenblock1, Romy Walther1, Sergey Tselmin1
1Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|September 16, 2022
Summary
Long/Post COVID presents a global health challenge, with up to 20% of SARS-CoV-2 patients experiencing persistent symptoms. This summary reviews clinical experiences with extracorporeal apheresis for Long/Post COVID patients in Germany.
Area of Science:
- Medical research
- Public health
- Infectious diseases
Background:
- Long/Post COVID is a growing global health and socioeconomic challenge.
- Up to 20% of SARS-CoV-2 survivors experience persistent, clinically relevant symptoms.
- Key symptoms include chronic fatigue, dyspnea, and cognitive dysfunction.
Purpose of the Study:
- To summarize clinical experiences with extracorporeal apheresis for Long/Post COVID.
- To provide insights into current treatment practices in the absence of randomized controlled trial data.
- To consolidate practitioner and center experiences with apheresis in Germany.
Main Methods:
- Review of clinical experience with extracorporeal apheresis.
- Data compilation from multiple German centers treating Long/Post COVID patients.
- Focus on practical application and observed outcomes.
Main Results:
- Extracorporeal apheresis is being utilized for Long/Post COVID symptom management.
- Numerous patients are currently undergoing apheresis treatment.
- No randomized controlled trial data currently exists to confirm efficacy.
Conclusions:
- Physicians currently rely on practitioner experience for apheresis in Long/Post COVID.
- Further research, including randomized controlled trials, is needed to validate apheresis efficacy.
- This summary offers a current overview of clinical practice in Germany.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
25
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
25
01:24Hemodialysis II: Procedure and Complications
120
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
120
02:45Blood Transfusion and Agglutination
11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K